These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36950087)
1. Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy. Guo Y; Yonamine S; Jian Ma C; Stewart JM; Acharya N; Arnold BF; McCulloch C; Sun CQ Ophthalmol Sci; 2023 Jun; 3(2):100276. PubMed ID: 36950087 [TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Health Insurance Status and Diabetic Retinopathy Progression. Guo Y; Copado IA; Yonamine S; Jian Ma C; McLeod S; Arnold BF; McCulloch CE; Sun CQ Ophthalmol Sci; 2024; 4(3):100458. PubMed ID: 38317868 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Diagnosis Codes to Clinical Notes in Classifying Patients with Diabetic Retinopathy. Yonamine S; Ma CJ; Alabi RO; Kaidonis G; Chan L; Borkar D; Stein JD; Arnold BF; Sun CQ Ophthalmol Sci; 2024; 4(6):100564. PubMed ID: 39253554 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723 [TBL] [Abstract][Full Text] [Related]
5. Individual and Systems-Based Risk Factors for Diabetic Vitrectomy in an Urban Safety-Net Hospital. Micevych PS; Taha AM; Poddar A; Stewart JM Ophthalmol Retina; 2023 Dec; 7(12):1027-1034. PubMed ID: 37236319 [TBL] [Abstract][Full Text] [Related]
6. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy. Meer E; Bavinger JC; Yu Y; VanderBeek BL JAMA Ophthalmol; 2022 May; 140(5):529-532. PubMed ID: 35389455 [TBL] [Abstract][Full Text] [Related]
7. Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice. Moshfeghi AA; Khurana RN; Moini H; Sherman S; Reed K; Boucher N; Rahimy E BMC Ophthalmol; 2024 May; 24(1):229. PubMed ID: 38822279 [TBL] [Abstract][Full Text] [Related]
8. The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy. Lee CS; Lee AY; Baughman D; Sim D; Akelere T; Brand C; Crabb DP; Denniston AK; Downey L; Fitt A; Khan R; Mahmood S; Mandal K; Mckibbin M; Menon G; Lobo A; Kumar BV; Natha S; Varma A; Wilkinson E; Mitry D; Bailey C; Chakravarthy U; Tufail A; Egan C; Am J Ophthalmol; 2017 Aug; 180():64-71. PubMed ID: 28572062 [TBL] [Abstract][Full Text] [Related]
9. Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy. Kawai K; Murakami T; Mori Y; Ishihara K; Dodo Y; Terada N; Nishikawa K; Morino K; Tsujikawa A Ophthalmol Sci; 2023 Mar; 3(1):100241. PubMed ID: 36545265 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis. Yang QH; Zhang Y; Zhang XM; Li XR Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489 [TBL] [Abstract][Full Text] [Related]
11. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity. Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083 [TBL] [Abstract][Full Text] [Related]
12. Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice. Moshfeghi A; Garmo V; Sheinson D; Ghanekar A; Abbass I Clin Ophthalmol; 2020; 14():3651-3659. PubMed ID: 33154625 [TBL] [Abstract][Full Text] [Related]
13. Alterations in the Choroidal Sublayers in Relationship to Severity and Progression of Diabetic Retinopathy: A Swept-Source OCT Study. Kung EWT; Chan VTT; Tang Z; Yang D; Sun Z; Wang YM; Chan CH; Kwan MCH; Shi J; Cheung CY Ophthalmol Sci; 2022 Jun; 2(2):100130. PubMed ID: 36249687 [TBL] [Abstract][Full Text] [Related]
14. Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario. Makwana T; Takkar B; Venkatesh P; Sharma JB; Gupta Y; Chawla R; Vohra R; Kriplani A; Tandon N Indian J Ophthalmol; 2018 Apr; 66(4):541-546. PubMed ID: 29582816 [TBL] [Abstract][Full Text] [Related]
15. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy. Li Y; Yu Y; VanderBeek BL Eye (Lond); 2020 May; 34(5):934-941. PubMed ID: 31586167 [TBL] [Abstract][Full Text] [Related]
17. Statin use and the risk of progression to vision threatening diabetic retinopathy. Meer E; Bavinger JC; Yu Y; Hua P; McGeehan B; VanderBeek BL Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):652-660. PubMed ID: 35253307 [TBL] [Abstract][Full Text] [Related]
18. Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy. Chen DJ; Kuo JC; Wright AJ; Chuang AZ; Chan W; Feldman RM; Crowell EL J Ophthalmol; 2021; 2021():6064525. PubMed ID: 34888097 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study. Pidro A; Ahmedbegovic-Pjano M; Grisevic S; Sofic-Drino V; Gabric K; Biscevic A Mater Sociomed; 2019 Dec; 31(4):290-293. PubMed ID: 32082096 [TBL] [Abstract][Full Text] [Related]
20. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy. Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]